83 related articles for article (PubMed ID: 21035484)
1. Targeting the cancer initiating cell: the Achilles' heel of cancer.
McCubrey JA; Chappell WH; Abrams SL; Franklin RA; Long JM; Sattler JA; Kempf CR; Laidler P; Steelman LS
Adv Enzyme Regul; 2011; 51(1):152-62. PubMed ID: 21035484
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
[TBL] [Abstract][Full Text] [Related]
3. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
5. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
Ping SY; Hour TC; Lin SR; Yu DS
Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
[TBL] [Abstract][Full Text] [Related]
6. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
7. Dietary genistein inhibits metastasis of human prostate cancer in mice.
Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
9. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor and prostate cancer invasion.
Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E
Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012
[TBL] [Abstract][Full Text] [Related]
11. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
12. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
Naik HR; Lehr JE; Pienta KJ
Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines.
Blagosklonny MV; Dixon SC; Figg WD
J Urol; 2000 Mar; 163(3):1022-6. PubMed ID: 10688042
[TBL] [Abstract][Full Text] [Related]
14. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
[TBL] [Abstract][Full Text] [Related]
15. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
16. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
[TBL] [Abstract][Full Text] [Related]
17. Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis.
McCubrey JA; Abrams SL; Fitzgerald TL; Cocco L; Martelli AM; Montalto G; Cervello M; Scalisi A; Candido S; Libra M; Steelman LS
Adv Biol Regul; 2015 Jan; 57():75-101. PubMed ID: 25453219
[TBL] [Abstract][Full Text] [Related]
18. Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.
Chen S; Principessa L; Isaacs JT
Prostate; 2012 Sep; 72(13):1478-89. PubMed ID: 22396312
[TBL] [Abstract][Full Text] [Related]
19. Differential remodeling of extracellular matrices by breast cancer initiating cells.
Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
[TBL] [Abstract][Full Text] [Related]
20. Targeting breast cancer initiating cells: advances in breast cancer research and therapy.
McCubrey JA; Davis NM; Abrams SL; Montalto G; Cervello M; Libra M; Nicoletti F; D'Assoro AB; Cocco L; Martelli AM; Steelman LS
Adv Biol Regul; 2014 Sep; 56():81-107. PubMed ID: 24913694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
